Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics (NASDAQ:UTHR – Get Rating) had its price objective cut by LADENBURG THALM/SH SH from $295.00 to $285.00 in a research note released on Thursday, The Fly reports. Several other equities research analysts have also recently weighed in on UTHR. The Goldman Sachs Group started coverage on United Therapeutics in a research note on […]
Cwm LLC grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 132.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 314 shares of the biotechnology company’s stock after acquiring an additional 179 shares during the […]
Cetera Investment Advisers bought a new position in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 956 shares of the biotechnology company’s stock, valued at approximately $225,000. A number of other institutional investors also recently bought and sold shares of […]
Northern Trust Corp reduced its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 1.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 336,544 shares of the biotechnology company’s stock after selling 5,751 shares during the quarter. Northern Trust Corp’s holdings in United Therapeutics were worth $79,303,000 at the end […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) EVP Paul A. Mahon sold 6,000 shares of the stock in a transaction on Thursday, December 1st. The shares were sold at an average price of $277.65, for a total value of $1,665,900.00. Following the completion of the sale, the executive vice president now directly owns 36,397 shares […]